GERN CIK: 886744

Geron Corporation

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−95.6
FY22:
−127
FY23:
−168
FY24:
−219
FY25:
−111
Change from FY21 to FY25
millions USD
FY21:
71.9
FY22:
62.1
FY23:
−180
FY24:
−106
FY25:
107
Change from FY21 to FY25
millions USD
FY21:
48.6
FY22:
87.3
FY23:
362
FY24:
334
FY25:
2.27
millions USD
FY21:
24.9
FY22:
22.0
FY23:
13.9
FY24:
9.74
FY25:
−1.44
(positive)
Change from FY21 to FY24
millions USD
FY21:
−95.8
FY22:
−128
FY23:
−169
FY24:
−219
FY25:
–

All amounts in millions USD Data source:SEC EDGAR